Skip to content

Clinical trials

Brain Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Country / region: United States Clear all

1,422 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200036
200127
200229
200331
200445
200550
200649
200758
200852
200964
201057
201150
201253
201345
201454
201557
201664
201764
201849
201953
202042
202146
202259
202349
202443
202545
202652

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed755
Terminated226
Recruiting201
Active, not recruiting120
Withdrawn53
Unknown status38
Not yet recruiting15
Suspended8
Enrolling by invitation5
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)130
M.D. Anderson Cancer Center78
Duke University66
Memorial Sloan Kettering Cancer Center51
Case Comprehensive Cancer Center29
Mayo Clinic28
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins26
St. Jude Children's Research Hospital24
Children's Oncology Group22
Massachusetts General Hospital21

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms1,422
Glioblastoma483
Glioma369
Astrocytoma268
Central Nervous System Neoplasms248
Gliosarcoma240
Oligodendroglioma188
Neoplasms138
Breast Neoplasms109
Neoplasm Metastasis107

Trials

Showing 26 to 50 of 1,422. Each trial links to its page on Pharma Observatory.

1,322 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.